Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -7.34%350.29K | -69.77%229.52K | -52.28%384.17K | 5.00%2.17M | -54.83%222.82K | -20.92%378.04K | 51.51%759.33K | 36.53%805.03K | 44.08%2.06M | 12.05%493.25K |
| Operating revenue | -7.34%350.29K | -69.77%229.52K | -52.28%384.17K | 5.00%2.17M | -54.83%222.82K | -20.92%378.04K | 51.51%759.33K | 36.53%805.03K | 44.08%2.06M | 12.05%493.25K |
| Cost of revenue | 80.87%235.54K | -34.49%216.15K | -10.59%199.26K | 188.88%1.05M | 620.63%370.82K | 51.77%130.23K | 214.97%329.94K | 81.49%222.87K | 0.14%364.81K | 11.85%51.46K |
| Gross profit | -53.70%114.75K | -96.89%13.37K | -68.24%184.91K | -34.52%1.11M | -133.50%-148K | -36.82%247.81K | 8.31%429.39K | 24.70%582.16K | 59.08%1.7M | 12.08%441.79K |
| Operating expense | -1.20%1.73M | 51.48%1.62M | 95.39%1.41M | -3.29%4.51M | -24.04%975.05K | 25.21%1.75M | 7.18%1.07M | -27.84%719.93K | 2.42%4.66M | 8.92%1.28M |
| Selling and administrative expenses | -5.59%1.15M | 80.04%1.17M | 329.07%1.02M | -10.17%2.56M | -45.97%447.52K | 30.45%1.22M | 16.45%650.65K | -55.48%237.36K | -0.18%2.85M | 9.09%828.34K |
| -Selling and marketing expense | 10.19%92.8K | 33.68%70.58K | -8.42%15.47K | -23.29%422.18K | 81.57%268.27K | -74.90%84.22K | -2.97%52.8K | 34.26%16.89K | 5.78%550.34K | -15.50%147.76K |
| -General and administrative expense | -6.75%1.06M | 84.13%1.1M | 354.92%1M | -7.03%2.14M | -73.66%179.25K | 89.22%1.14M | 18.54%597.85K | -57.65%220.47K | -1.51%2.3M | 16.44%680.59K |
| Research and development costs | --1.14K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Depreciation amortization depletion | 14.87%236.39K | 64.13%238.31K | -22.30%212.54K | -8.58%833.3K | -7.73%208.78K | -10.82%205.79K | -34.69%145.19K | 17.84%273.54K | 0.52%911.46K | -3.70%226.26K |
| -Depreciation and amortization | 14.87%236.39K | 64.13%238.31K | -22.30%212.54K | -8.58%833.3K | -7.73%208.78K | -10.82%205.79K | -34.69%145.19K | 17.84%273.54K | 0.52%911.46K | -3.70%226.26K |
| Other operating expenses | 4.91%334.47K | -23.94%205.91K | -15.94%175.71K | 23.75%1.12M | 39.16%318.76K | 40.15%318.81K | 26.49%270.71K | -10.02%209.03K | 13.97%902.87K | 24.35%229.06K |
| Operating profit | -7.48%-1.61M | -151.47%-1.6M | -786.85%-1.22M | -14.59%-3.4M | -33.40%-1.12M | -49.46%-1.5M | -6.43%-637.16K | 74.05%-137.76K | 14.92%-2.96M | -7.34%-841.87K |
| Net non-operating interest income (expenses) | 22.69%-411.81K | 31.93%-394.08K | -29.31%-442.89K | -39.53%-1.93M | -28.80%-471.83K | -19.64%-532.66K | -118.02%-578.95K | -12.96%-342.5K | -26.68%-1.38M | -29.27%-366.34K |
| Non-operating interest income | 158.79%7.98K | 240.01%7.76K | 291.20%8.85K | 1,490.48%27.56K | 1,302.89%19.94K | 2,782.24%3.08K | 1,013.17%2.28K | --2.26K | 79.96%1.73K | 108.97%1.42K |
| Non-operating interest expense | -21.64%419.79K | -30.87%401.83K | 31.03%451.74K | 41.35%1.95M | 33.72%491.76K | 20.30%535.75K | 118.71%581.24K | 13.71%344.76K | 26.73%1.38M | 29.46%367.76K |
| Other net income (expenses) | -101.32%-55.72K | 783.92%232.71K | 297.47%400.4K | 346.45%3.3M | -629.85%-694.52K | 4,182.97%4.23M | -131.08%-34.03K | -133.16%-202.76K | 234.62%738.67K | 658.60%131.08K |
| Gain on sale of security | -11,778.89%-90.75K | 401.75%205.04K | 97.63%-4.74K | -267.32%-340.17K | -143.18%-73.22K | 100.78%777 | -151.02%-67.95K | -240,802.41%-199.78K | 150.08%203.3K | 127.45%169.57K |
| Special income (charges) | -99.17%35.03K | -22.71%27.67K | --405.14K | 593.91%3.64M | -1,137.42%-620.96K | 137,835.75%4.23M | 202.60%35.8K | --0 | 499.81%525.25K | 8.53%-50.18K |
| -Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Impairment of capital assets | --0 | ---- | ---- | 614.73%363.38K | 2,891.37%364.41K | -133.41%-1.03K | --0 | --0 | 1.08%50.84K | 2,372.76%12.18K |
| -Less:Other special charges | ---- | 22.71%-27.67K | ---405.14K | -569.99%-4.11M | --150.35K | ---4.23M | ---35.8K | ---- | ---614.09K | --0 |
| -Less:Write off | ---35.03K | ---- | ---- | 179.49%106.21K | --106.21K | --0 | ---- | ---- | -53.13%38K | ---- |
| Other non-operating income (expenses) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --12.54K | ---- |
| Income before tax | -194.62%-2.08M | -41.07%-1.76M | -85.10%-1.26M | 43.84%-2.03M | -112.55%-2.29M | 241.57%2.2M | -65.64%-1.25M | -206.94%-683.02K | 29.60%-3.61M | -2.54%-1.08M |
| Income tax | -103.27%-667.09K | -328.18K | ||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -194.62%-2.08M | -41.07%-1.76M | -85.10%-1.26M | 58.56%-1.36M | -116.61%-1.62M | 241.57%2.2M | -65.64%-1.25M | -206.94%-683.02K | 36.01%-3.28M | 28.70%-748.94K |
| Net income continuous operations | -194.62%-2.08M | -41.07%-1.76M | -85.10%-1.26M | 58.56%-1.36M | -116.61%-1.62M | 241.57%2.2M | -65.64%-1.25M | -206.94%-683.02K | 36.01%-3.28M | 28.70%-748.94K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -194.62%-2.08M | -41.07%-1.76M | -85.10%-1.26M | 58.56%-1.36M | -116.61%-1.62M | 241.57%2.2M | -65.64%-1.25M | -206.94%-683.02K | 36.01%-3.28M | 28.70%-748.94K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -194.62%-2.08M | -41.07%-1.76M | -85.10%-1.26M | 58.56%-1.36M | -116.61%-1.62M | 241.57%2.2M | -65.64%-1.25M | -206.94%-683.02K | 36.01%-3.28M | 28.70%-748.94K |
| Diluted earnings per share | -200.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | 50.00%-0.01 | -0.01 | 200.00%0.01 | 0.00%-0.01 | -493.12%-0.01 | 60.00%-0.02 | 0 |
| Basic earnings per share | -200.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | 50.00%-0.01 | -0.01 | 200.00%0.01 | 0.00%-0.01 | -493.12%-0.01 | 60.00%-0.02 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.